What Is Photoacoustic Imaging?

Photoacoustic imaging (PAI) is a hybrid biomedical imaging modality that combines the spectroscopic selectivity of optical imaging with the spatial resolution and depth penetration of ultrasound. It works by directing short laser pulses into biological tissue, where chromophores such as hemoglobin, melanin, and lipids absorb optical energy, convert it to heat, and generate thermoelastic pressure waves. These acoustic waves are detected by ultrasound transducers and reconstructed into two- or three-dimensional maps of optical absorption. Because the acoustic signal, rather than light, is what carries spatial information out of the tissue, PAI is not limited by optical scattering in the same way as purely optical techniques.

The modality was developed through the convergence of pulsed laser technology, piezoelectric transducer arrays, and tomographic reconstruction algorithms in the 1990s and early 2000s. It occupies a distinct position between optical coherence tomography, which provides sub-micron resolution at sub-millimeter depths, and conventional ultrasound, which images at centimeter depths but with no optical contrast specificity.

Imaging Principles and System Architecture

A photoacoustic imaging system consists of a pulsed laser source, a coupling medium between tissue and transducer, an ultrasound detection array, and an image reconstruction unit. The laser generates nanosecond-duration pulses at wavelengths in the visible to near-infrared range, selected to match the absorption spectra of the chromophores of interest. Typical pulse repetition rates are 10 to 100 Hz for mechanically scanned systems; real-time systems using arrays achieve frame rates above 50 Hz.

Ultrasound detection is accomplished with piezoelectric transducers using materials such as polyvinylidene fluoride (PVDF), or with optical detectors based on Fabry-Perot etalons. Array-based systems permit simultaneous reception from multiple directions, enabling rapid image reconstruction without mechanical scanning. Research reviewed in a PMC survey of photoacoustic devices for biomedical applications describes how beam-steering approaches including MEMS platforms and galvanometer scanners are being used to miniaturize systems for handheld and endoscopic configurations.

Imaging Modes and Resolution

Three principal imaging modes have been developed, each offering a different trade-off between resolution and depth. Photoacoustic tomography (PAT) uses wide-field illumination and records acoustic signals from multiple transducer positions around or above the sample, then applies filtered backprojection or time-reversal reconstruction to recover absorption maps at depths of several centimeters with millimeter-scale resolution. Acoustic-resolution photoacoustic microscopy (AR-PAM) focuses the ultrasound beam to achieve approximately 45-micron lateral resolution at depths of 3 to 4 mm. Optical-resolution photoacoustic microscopy (OR-PAM) tightly focuses the excitation laser to achieve lateral resolution below 5 microns, but only to depths of about 1 mm because of optical scattering.

The PMC review of biomedical photoacoustic imaging established the theoretical framework for these three modes and documented early demonstrations of functional imaging of blood oxygenation using the differential absorption of oxy- and deoxyhemoglobin at multiple wavelengths.

Contrast Mechanisms and Functional Imaging

The primary endogenous contrast agents for PAI are hemoglobin (absorbing strongly in the 500 to 600 nm range), melanin (absorbing from the ultraviolet through the near-infrared), water, and lipids. By acquiring images at two or more wavelengths, quantitative maps of blood oxygen saturation can be computed from the ratio of oxyhemoglobin to total hemoglobin concentrations, a capability not available in conventional ultrasound. Exogenous contrast agents including gold nanoparticles, indocyanine green (ICG) dye, and carbon nanotube formulations can be administered to enhance contrast in targeted tissues or to map drug delivery.

The npj Imaging review of deep tissue photoacoustic imaging discusses how multi-wavelength spectral unmixing and deep learning reconstruction methods are extending the depth and accuracy of quantitative functional imaging in preclinical and clinical settings.

Applications

Photoacoustic imaging has applications across clinical medicine and preclinical research, including:

• Tumor detection and margin assessment using vascular imaging of neovascularization
• Blood oxygen saturation mapping in brain and peripheral vascular disease
• Melanoma and skin lesion characterization in dermatology
• Breast imaging and thyroid assessment as alternatives to biopsy
• Intraoperative guidance and drug delivery monitoring